| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |